Skip to content

Pharmacie DEMANET

Active
Private limited companyfounded 2005active for 20 yearsRue Edouard Dinot 32, 5590 Ciney, BelgiumKBO/BCE: BE 0878.190.191
Summary

Pharmacie DEMANET has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€43,839) and a net result of €26,809. Equity has been growing by about 6.9% per year since 2018. Its solvency ranks better than 18% of 22,774 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).

Overview

Official details

Source: KBO
Status
Active since 27-12-2005 Normal situation
Registered office
13 active companies are registered at this address Source: KBO register, as of 3 November 2026.
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.151.056.657 1360 Perwez, since 09-01-2006
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
Auditor
Callens, Vandelanotte & Theunissen SRL

Financial position

55 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.3%
Annual accounts 2025
Gross margin
€152,025
▼ 4.7%
Turnover
≈ €480,000
estimated
Profit
€26,809
▼ 38.5%
Equity
-€43,839
▲ 37.9%
Total assets
€331,843
▲ 0.1%
Employees on 31-12-2025
2
=
  • Negative equity on 31-12-2025
  • 2025 accounts filed 20 days after the deadline
Score breakdownraises riskCapped at 59: negative equityNegative equity -€43,8391 change of registered office in 24 monthsSector: Retail trade (NACE 47)lowers riskSize: total assets €331,843Show the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 47% of micro companies in retail trade (NACE 47)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 12+8
equity -13.2% of total assets
Liquidity 25+3
short-term debt 113.2% · cash 20.2%
Profitability 79-6
return on assets 8.1%
Bankruptcy probability within 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.7% 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.8%▲ +0.1 percentage points vs 03-2025 05-2025: 0.7%▼ -0.1 percentage points vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.2 percentage points vs 06-2025 08-2025: 1.2%▲ +0.3 percentage points vs 07-2025 09-2025: 0.6%▼ -0.6 percentage points vs 08-2025 10-2025: 0.6%● unchanged vs 09-2025 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.5%▼ -0.1 percentage points vs 04-2026lowest value 06-2026: 1.4%▲ +0.9 percentage points vs 05-2026 07-2026: 1.4%● unchanged vs 06-2026 08-2026: 2.0%▲ +0.6 percentage points vs 07-2026highest value 09-2026: 1.3%▼ -0.7 percentage points vs 08-2026 10-2026: 1.3%● unchanged vs 09-2026 11-2026: 1.3%● unchanged vs 10-2026
No credit on open account
Liquidity is insufficient, with a current ratio of 0.54 (0.46 in 2024), below 1. Short-term debt is 113.2% and cash 20.2% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 15% of them on solvency, 23% on liquidity, 69% on profitability and 83% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Negative equity -€43,839
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Size: total assets €331,843
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 22774 sector peers (2025).
NBB · sector comparison
Position among 22774 sector peers
Solvency
better than 18%
← weakest strongest →
raises risk · 2025 accounts filed 20 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
20 days late
2024
20 days late
2023
28 days late
2022
29 days late
2021
26 days late
2020
26 days late
2019
24 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€43,839 View
  • Caution: Less equity than 90% of companies in retail tradesector median €41,218 · 22,816 companies -€43,839 View
  • Board changedlatest change 21-05-2026 · 3 in office 3 joined · 2 left View

Recent changes

  1. · Gazette deed Restructuring
  2. · Gazette deed Registered office moved from Perwez to CineyNew seat: rue E. Dinot 32 à 5590 Ciney · Previous seat: RUE DE LA STATION, 26 à 1360 PERWEZ · Resignations: Pierre DEMANET (manager) and Françoise DEMANET (manager)
  3. · Gazette deed Changes of role: DEMANET Pierre (director) and DEMANET Françoise (director)
All 18 events

Comparable companies

These companies have the same main activity as Pharmacie DEMANET: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €287,000 and €369,000, founded between 2004 and 2007.

CompanyTotal assetsGross margin
Pharmacie DEMANET Ciney€331,843€152,025
I & CM MARBOTIN Schaarbeek€323,588€152,686
OMNIPHAR Ronse€369,071€153,274
PHARMACIE LHÔTE La Louvière€297,427€149,117
PHARMACIE NYSTEN Anhée€286,570€138,454
Apotheek Dehaen Koen Mortsel€307,018€136,638
DOLCEPHARMA Gent€304,973€166,450
Full comparison

Key facts about Pharmacie DEMANET

What is the company number of Pharmacie DEMANET?
The company number of Pharmacie DEMANET is 0878.190.191. The VAT number is the same number with BE in front: BE 0878.190.191.
Where is Pharmacie DEMANET based?
The registered office is at Rue Edouard Dinot 32, 5590 Ciney.Company details
What does Pharmacie DEMANET do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Pharmacie DEMANET?
The legal form of Pharmacie DEMANET is Private limited company (BV).
When was Pharmacie DEMANET founded?
Pharmacie DEMANET was founded on 27-12-2005.
Is Pharmacie DEMANET still active?
Yes, Pharmacie DEMANET is an active enterprise in the KBO register.
How many employees does Pharmacie DEMANET have?
Pharmacie DEMANET had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Pharmacie DEMANET?
The turnover in financial year 2025 is ≈ €480,000. This figure is estimated from the gross margin of €152,025 and 32 comparable companies (NACE 477). It probably lies between €330,000 and €940,000. In financial year 2023 turnover was €879,082.
Is Pharmacie DEMANET profitable?
In financial year 2025, Pharmacie DEMANET made a profit of €26,809.
Where can I find the annual accounts of Pharmacie DEMANET?
Pharmacie DEMANET filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Pharmacie DEMANET due?
Pharmacie DEMANET must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.